Early Prediction of Postpartum Glucose Metabolism Abnormalities in Gestational Diabetes Mellitus
Launched by WOMEN'S HOSPITAL SCHOOL OF MEDICINE ZHEJIANG UNIVERSITY · Jan 1, 2023
Trial Information
Current as of July 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is researching how to better predict glucose metabolism issues in women who have gestational diabetes mellitus (GDM) after giving birth. Gestational diabetes occurs during pregnancy and can lead to problems with blood sugar levels after delivery. The researchers are using advanced technology to analyze blood samples from pregnant women to find reliable markers that can help identify those at risk of developing glucose metabolism abnormalities after childbirth. The goal is to create a system that can alert healthcare providers early, so they can take steps to manage these risks effectively.
To be eligible for this study, participants need to be women who are planning to have their prenatal check-ups and deliver their baby at the research center. They must have been diagnosed with GDM between 24 and 28 weeks of pregnancy and should be having a single baby without any other complications. Participants can expect to provide blood samples for testing and will be followed closely by the research team to monitor their health. This study aims to improve care for women with GDM and help them avoid potential health issues after giving birth.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Plan to have routine prenatal examinations and give birth in the research center
- • GDM was diagnosed at 24-28 gestational weeks
- • Singleton pregnancy
- • Without other pregnancy complications
- • Willing to cooperate with the hospital to follow up
- Exclusion Criteria:
- • Have diseases that affect metabolic function or even threaten the life of the mother and fetus before pregnancy, such as diabetes, heart disease, liver and kidney diseases, thyroid diseases with drug, autoimmune diseases, malignant tumors, AIDS, etc.
- • Fetus has a known deformity or genetic defects
- • Incomplete clinical data
About Women's Hospital School Of Medicine Zhejiang University
The Women’s Hospital School of Medicine at Zhejiang University is a leading academic institution dedicated to advancing women's health through innovative research and clinical excellence. With a strong focus on obstetrics, gynecology, and reproductive health, the institution conducts cutting-edge clinical trials aimed at improving patient outcomes and enhancing the understanding of women's health issues. Committed to fostering collaboration between researchers, healthcare professionals, and patients, the Women's Hospital School of Medicine plays a pivotal role in translating scientific discoveries into effective healthcare solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hangzhou, Zhejiang, China
Patients applied
Trial Officials
Zhaoxia Liang, Prof.
Study Director
Women's Hospital School Of Medicine Zhejiang University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials